Phase 2 BESTOW trial generates promising kidney function and quality of life results for tegoprubart versus tacrolimus immunosuppression in kidney transplant recipients
Dana-Farber presents Phase 3 lung cancer data in ESMO Presidential Symposium
NASA Glenn Invites Phase 1 Proposals for Aerospace Power Systems Laboratory
Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial
Novel three-phase-coexisting anode boosts green hydrogen production in protonic solid oxide electrolysis cells
Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders
Novel dual-target IL-17A/F monoclonal antibody XKH004 shows 52-week efficacy and safety in active ankylosing spondylitis in phase 3 trial
Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer
Phase 1 study supports recommended phase 3 dose for investigational EGFR x HER3 antibody-drug conjugate in EGFR-mutated lung cancer
Phase 1 Study Supports Recommended Phase 3 Dose for Investigational EGFR x HER3 Antibody-Drug Conjugate in EGFR-Mutated Lung Cancer
NASA Awards First Prize in Phase 2 of Agency’s LunaRecycle Challenge
Insilico Medicine announces oral presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in mesothelioma and advanced solid tumors - EurekAlert!
Holographic 3D printing with phase light modulators boosts efficiency 70? —and enables multi-scale printing - EurekAlert!
Reversible optical data storage and encryption enabled by phase-change and hydrogel integration - EurekAlert!
Multimodal imaging: A highly integrated fluorescence-phase microscopy system - EurekAlert!
A phase I-II study of niacin in patients with newly diagnosed glioblastoma: safety and interim phase II analysis
Insilico completes first-in-human dosing in phase I clinical study of AI-driven NLRP3 inhibitor ISM8969, achieving first clinical milestone in collaboration with Hgtia - EurekAlert!
World first: First phase 3 trial of in vivo CRISPR therapy successfully completed CRISPR treatment comes one step closer to reality - EurekAlert!
World first: First phase 3 trial of in vivo CRISPR therapy successfully completed CRISPR treatment comes one step closer to reality - EurekAlert!
